Granite Ridge Resources clears the business-activity screen and the figures we can measure look clean, but one or more financial figures are still pending, so the verdict is not final yet.
Granite Ridge Resources Inc
GRNT · the NYSE · USD · Market cap $773M · 6 employees
Granite Ridge Resources, Inc.
Not yet scoredPrice as of 4 Nov 2026Daily close, not a live quote
Screened 2026-11-04 · the tape above runs as of 20:03 UTC · two dates, stated on purpose · verdict and workings shown in full · never trimmed
Key facts today
- Price4.63 USD at the 4 Nov 2026 close
- Fair valueUnder review: our model's value is 1.56x the price, above our 1.35x limit.
- Our regime readMarkup, as of 4 Nov 2026
- Ethical screenNot yet scored
- OptionsOpen interest leans slightly to calls (put/call 0.93)
- Last reviewed4 Nov 2026 (1 days ago)
- Release timesRelease and earnings times on your chart: Event Guard Mentor
A summary of the dated readings below, not a live quote and not advice.
Our fair-value range: range not available (screen dated 2026-11-04).
- Trend Markup
- Insiders no filings inside 60 days, left as found
- Positioning no disclosures inside 60 days, left as found
- Options put/call open interest 0.93, read 2026-11-05
- Ethical screen not yet scored
Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.
This name holds its markup label.
Granite Ridge Resources Inc holds its Markup at $4.63. The statistical read favours the buyers, held for 101 days.
| Phase | Markup |
| Quantitative state | The statistical read favours the buyers, held for 101 days |
| Price at the screen | $4.63 |
| Valuation | N/A trailing · 6.62 forward price to earnings |
| Values screen | Not scored · score 70.0 |
| Beta | 0.20 |
Five Screens, Shown in Full
This security has not been fully scored against the values screen yet.
| Test | Figure | Limit | What it means | Status |
|---|---|---|---|---|
| Business activity | Permissible | Core business clean | Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending. | Pass |
| Debt load | 32.99% | Below 33% | Interest-bearing debt is just 33.0% of its assets, well under the one-third ceiling: it does not run on borrowed money. | Pass |
| Interest-bearing cash | 0.94% | Below 33% | Cash held in interest-bearing accounts and securities is 0.9% of assets, under the one-third limit. | Pass |
| Receivables | 7.62% | Below 49% | Money owed to the company is 7.6% of assets, under the 49% limit. | Pass |
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
The Ethical ReadThe Read, in Plain English
Granite Ridge Resources clears the business-activity screen and the figures we can measure look clean, but one or more financial figures are still pending, so the verdict is not final yet.
Read as at 2026-11-05. It updates when the underlying figures move, and past reads are kept below.
Granite Ridge Resources clears all five screens. Its business is in a permissible area, its interest-bearing debt is about 33%, inside the ~33% line, and almost none of its income is interest, so it passes.
Earlier reads, kept as written. The ethical profile is tracked over time, not overwritten.
What the Numbers Say It Is WorthThe Fair Value Range
Fair value under review. Our model's value is 1.56x the price, above our 1.35x limit. We show no fair value, margin of safety or value read built on it until the review clears.
How a fair value is estimated: discounted cash flow (DCF).
The Street's RangeThird-party analyst targets: 5 covering, consensus Buy. The average target sits +51% from the screen price.
Where our models see it going: no fair-value estimate yet, range not available, dated to the 2026-11-04 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain Words| Forward P/E | 6.6xcheap for a company growing this fast |
| EPS, trailing | -0.22 |
| EPS, forward | 0.89 |
| Revenue growth | +37.3%strong top-line growth |
| Profit margin | -5.8%currently unprofitable |
| Return on equity | -4.6%not currently earning a positive return on equity |
| FCF yield | -11.29% |
| Dividend yield | 894.00% |
| Debt to equity | 0.82moderate, manageable leverage |
| Current ratio | 1.02adequate liquidity, worth monitoring |
| Beta | 0.20barely tracks the market's swings |
| Short interest, float | 0.10% |
| 52-week range | 4.18 - 6.15 |
| Moat | NONE |
| Market cap | $773M |
| Employees | 6 |
Another profit measure, before interest, tax and non-cash costs: EBITDA.
The risks · The things to watch: it's a small-cap, so the share price can swing harder than the market.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to TradeGRNT trades on the NYSE. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
Every Entry, As Written
The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 9.4% since our last review. Ethical screening: not fully scored yet. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 18% above its long-term trend line with momentum reading overbought. Over the past year the shares are down 8%. Our forward projection puts the odds of a 10% gain over the next month near 21%. The street (4 analysts) rates it none, with a mean price target of $8. It reported earnings in this window, a natural checkpoint for the thesis.
The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 10.8% since our last review. Ethical screening: not fully scored yet. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 18% above its long-term trend line with momentum reading overbought. Over the past year the shares are down 8%. Our forward projection puts the odds of a 10% gain over the next month near 21%. The street (4 analysts) rates it none, with a mean price target of $8. It reported earnings in this window, a natural checkpoint for the thesis.
The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: not fully scored yet. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 18% above its long-term trend line with momentum reading overbought. Over the past year the shares are down 8%. Our forward projection puts the odds of a 10% gain over the next month near 21%. The street (4 analysts) rates it none, with a mean price target of $8. It reported earnings in this window, a natural checkpoint for the thesis.
The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: not fully scored yet. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 18% above its long-term trend line with momentum reading overbought. Over the past year the shares are down 8%. Our forward projection puts the odds of a 10% gain over the next month near 21%. The street (4 analysts) rates it none, with a mean price target of $8. It reported earnings in this window, a natural checkpoint for the thesis.
The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 2.2% since our last review. Ethical screening: not fully scored yet. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it A, carrying a low risk profile. Technically it is holding around 18% above its long-term trend line with momentum reading overbought. Over the past year the shares are down 8%. Our forward projection puts the odds of a 10% gain over the next month near 21%. The street (4 analysts) rates it none, with a mean price target of $8. It reported earnings in this window, a natural checkpoint for the thesis.
The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: not fully scored yet. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it A, carrying a low risk profile. Technically it is holding around 18% above its long-term trend line with momentum reading overbought. Over the past year the shares are down 8%. Our forward projection puts the odds of a 10% gain over the next month near 21%. The street (4 analysts) rates it none, with a mean price target of $8. It reported earnings in this window, a natural checkpoint for the thesis.
The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: not fully scored yet. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it A, carrying a low risk profile. Technically it is holding around 18% above its long-term trend line with momentum reading overbought. Over the past year the shares are down 8%. Our forward projection puts the odds of a 10% gain over the next month near 21%. The street (4 analysts) rates it none, with a mean price target of $8. It reported earnings in this window, a natural checkpoint for the thesis.
The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: not fully scored yet. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it A, carrying a low risk profile. Technically it is holding around 18% above its long-term trend line with momentum reading overbought. Over the past year the shares are down 8%. Our forward projection puts the odds of a 10% gain over the next month near 21%. The street (4 analysts) rates it none, with a mean price target of $8. It reported earnings in this window, a natural checkpoint for the thesis.
The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 15.1% since our last review. Ethical screening: not fully scored yet. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it A, carrying a low risk profile. Technically it is holding around 18% above its long-term trend line with momentum reading overbought. Over the past year the shares are down 8%. Our forward projection puts the odds of a 10% gain over the next month near 21%. The street (4 analysts) rates it none, with a mean price target of $8.
The framework has shifted from distribution to markup since the last review. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 6.7% since our last review. Ethical screening: not fully scored yet. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is momentum reading overbought. Over the past year the shares are down 8%. Our forward projection puts the odds of a 10% gain over the next month near 21%. The street (4 analysts) rates it none, with a mean price target of $8.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
- 3 Oil Stocks Worth Watching As Higher Crude Prices Lift Energy Cash Flow Yahoo Finance · 24d ago
- Permian Resources, Granite Ridge Resources, ExxonMobil, and Viper Energy Shares Skyrocket, What You Need To Know Yahoo Finance · 28d ago
- Granite Ridge Resources Schedules Third Quarter 2026 Earnings Conference Call Yahoo Finance · 5 Oct 2026
- 1 Oversold Stock Ready to Bounce Back and 2 Facing Challenges Yahoo Finance · 5 Oct 2026
- 3 Energy Stocks We Approach with Caution Yahoo Finance · 28 Sep 2026
Headlines from third-party outlets, linked for reference: not our reporting, not advice.
Screened names in the same industry · explore each on its own page.
| Period | Price then | Price return | Divs per share | $1,000 became | Total return |
|---|---|---|---|---|---|
| 1 month | $5.13 | -2.4% | $0.11 | $997 | -0.3% |
| 2 months | $5.45 | -8.0% | $0.11 | $940 | -6.0% |
| 3 months | $5.01 | +0.1% | $0.11 | $1,023 | +2.3% |
| 6 months | $4.92 | +1.9% | $0.22 | $1,064 | +6.4% |
| 1 year | $5.43 | -7.7% | $0.44 | $1,004 | +0.4% |
| 2 years | $5.41 | -7.4% | $0.88 | $1,089 | +8.9% |
| 3 years | $4.82 | +3.9% | $1.32 | $1,313 | +31.3% |
| 5 years | $7.43 | -32.6% | $1.62 | $892 | -10.8% |
Historical returns from market close data. Past performance does not guarantee future results.
This entry now belongs to the ledger. Whatever GRNT does next, these words stay.
Thirteen thousand names carry this page. One desk keeps them honest.
Membership opens the full screen archive, the composites built from it, and the daily coverage that prices what the screen approves.
Join the deskScreening is research, not a fatwa and not financial advice. Figures are drawn from public accounts at the screen date shown. Always manage your risk.